Lung transplantation and osteoporosis: A review

Clinical Pulmonary Medicine

Volumn 6, Issue 2, 1999, Pages 110-117

  Di Boscio, Valentina ^a,c   Sarli, Marcelo A ^b  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b Instituto de Investigaciones Metabolicas   (Argentina)

^c Capital Federal ^*  (Argentina)

Author keywords

Adverse effects; Drug induced osteoporosis; Immunosuppressive agents; Lung transplantation; Organ transplantation; Osteoporosis; Side effects

Indexed keywords

AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CYCLOSPORIN A; GLUCOCORTICOID; LEFLUNOMIDE; LYMPHOCYTE ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VITAMIN D;

BONE ATROPHY; BONE METABOLISM; CALCIUM BLOOD LEVEL; DISEASE ASSOCIATION; HORMONE SUBSTITUTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LUNG TRANSPLANTATION; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PATHOGENESIS; REVIEW; RISK FACTOR; VITAMIN BLOOD LEVEL;

EID: 0032908527     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199903000-00004     Document Type: Review

References (82)

1. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novik RJ. The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report -1998. J Heart Lung Transplant 1998;17:656-8.
2. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: fourteenth official report - 1997. J Heart Lung Transplant 1997;16:691-712.
3. Hosenpud JD, Novick RJ, Breen TJ, Keck B, Daily P. The Registry of the International Society for Heart and Lung Transplantation: twelfth official report - 1995. J Heart Lung Transplant 1995;14:805-15.
4. Hosenpud JD, Novick RJ, Bennett LE, Keck B, Fiol B, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report - 1996. J Heart Lung Transplant 1996;15:655-74.
5. Grupo cooperative Fundación Favaloro -Hospital Maria Ferrer. Medicina (B Aires) 1997;57:521-9.
6. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997;155:789-818.
7. Aris RM, Neuringer IP, Weiner MA, Egan TM, Ontjes D. Severe osteoporosis before and after lung transplantation. Chest 1996;109:1176-83.
8. Shane E, Silverberg SJ, Donovan D, et el. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996;101:262-9.
9. Ferrari SL, Nicod LP, Harnacher J, et al. Osteoporosis in patients undergoing lung transplantation. Eur Respir J 1996;9:2378-82.
10. Maurer JR. Medical complications following lung transplantation. Semin Respir Crit Care Med 1996;17:173-85.
11. Boot AM, Nauta J, Hokken-Koelega ACS, et al. Renal transplantation and osteoporosis. Arch Dis Child 1995;72:502-6.
12. Grotz WH, Mundinger FA, Rasenack J, et al. Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 1995;10:2096-100.
13. Coen G. Fracturing osteoporosis after kidney transplantation: what are the options? Nephrol Dial Transplant 1996;11:567-9.
14. Lee AH, Mull RL, Keenan GF, et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994;96:35-41.
15. Shane E, Rivas M, Silverberg SJ, et al. Osteoporosis after cardiac transplantation. Am J Med 1993;94:257-64.
16. García-Delgado I, Prieto S, Gil-Fraguas L, Robles E, Rufilanchas JJ, Hawkins F. Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int 1997;60:155-9.
17. Losowsky MS, Hussaini SH. Bone disease after liver transplantation. Gut 1996;39:505-7.
18. Monegal A, Navasa M, Guañabens N, et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997;60:148-54.
19. Abdelhadi M, Eriksson SAV, Eriksson SL, et al. Bone mineral status in end-stage liver disease and the effect of liver transplantation. Scand J Gastroenterol 1995;30:1210-5.
20. Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993;94:646-50.
21. Kanis JA and the World Health Organization (WHO) Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 1994;4:368-81.
22. Johnston C, Slemenda CH, Melton L. Bone density measurements and the management of osteoporosis. In: Favus MJ, editor. Primer on the metabolic bone disease and disorders of bone mineral metabolism. 3rd ed. Philadelphia: Lippincott-Raven, 1996:142-51.
23. Chaparro C, Kesten S, Scavuzzo M, et al. Osteoporosis in long-term survivors of isolated lung transplantation. Poster presentation, New Orleans ACCP annual meeting, November 2, 1994.
24. Aris R, Renner J, Winders A, et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 1998;128:186-93.
25. Katz IA, Epstein S. Perspectives posttransplantation bone disease. J Bone Miner Res 1992;7:123-6.
26. Epstein S, Shane E. Transplantation osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. 1st ed. San Diego: Academic Press, 1996:947-57.
27. Thiebaud D, Krieg MA, Gillard Berguer D, et al. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 1996;26:549-55.
28. Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 1996;11:1-7.
29. Reid IR. Pathogenesis and treatment of steroid Osteoporosis: review. Clin Endocrinol (Oxf) 1989;30:83-103.
30. Reid IR. Steroid Osteoporosis. Osteoporos Int 1993;3(1 Suppl):144-6.
31. Lukert B, Johnson B, Robinson R. Glucocorticoid-induced Osteoporosis. J Bone Miner Res 1992;7:1063-9.
32. Lukert B. Glucocorticoid-induced Osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. 1st edition. San Diego: Academic Press, 1996:801-19.
33. Olbright T, Benker G. Glucocorticoid-induced Osteoporosis: pathogenesis, prevention and treatment, with special regard to the rheumatic diseases. J Intern Med 1993;234:237-44.
34. Day JD, Walden SM, Stuart SR, et al. Fatal fat embolism syndrome after numerous vertebral body compression fractures in a lung transplant recipient. J Heart Lung Transplant 1994; 13:785-90.
35. Bachrach LK, Louitt CW, Moss RB, Marcus R. Osteopenia in adults with cystic fibrosis. Am J Med 1994;96:27-34.
36. Midthun DE, McDougall JC, Peters SG, Scott JP. Medical management and complications in the lung transplant patient. Mayo Clin Proc 1997;72:175-84.
37. Kahan BD. Cyclosporine. N Engl J Med 1989; 321:1725-38.
38. U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-5.
39. Movsowitz C, Epstein S, Ismail F, et al. Cyclosporine A in the oophorectomized rat: unexpected severe bone resorption. J Bone Miner Res 1989;4:393-8.
40. Klaushofer K, Hoffman O, Stewart P, et al. Cyclosporin A effects on resorption in neonatal mouse calvaria. J Pharmacol Exp Ther 1987; 243:580-4.
41. Delmas PD, Wilson DM, Mann KG, Riggs BL. Effect of renal function on plasma levels of bone Gla-protein. J Clin Endocrinol Metab 1983;57:1028-33.
42. Rivas MDC, Silverberg SJ, Kim TS, Shane E. Femoral neck bone loss predominates one year after cardiac transplantation [abstract]. J Bone Miner Res 1993;8:205.
43. Bryer HP, Isserow JA, Armstrong EC, et al. Azathioprine alone is bone sparing and does not alter cyclosporine induced osteopenia in the rat. J Bone Miner Res 1995;10:1-6.
44. Muchmore JS, Cooper DKS, Ye Y, et al. Loss of vertebral bone density in heart transplant patients. Transplant Proc 1991;23:1184-5.
45. Porayko MK, Wiesner RH, Hay JE, et al. Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 1991;23:1462-5.
46. Julian BA, Laskow DA, Dubovsky J, et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991;325: 544-50.
47. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Mcd 1994;331:365-76.
48. Grey A, Ames R, Matthews R, Reid I. Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax 1993;48:589-94.
49. Bachrach L, Loutit C, Moss R. Osteopenia in adults with cystic fibrosis. Am J Med 1994;96: 27-32.
50. Finkelstein J, Neer R, Biller B, Crawford J, Klibanski A. Osteopenia in men with history of delay puberty. N Engl J Med 1992;326:600-4.
51. Henderson R, Madsen C. Bone density in children and adolescents with cystic fibrosis. J Pediatr. 1996;128:28-34.
52. Bhudhikanok G, Lim J, Marcus R, Harkins A, et al. Correlates of Osteopenia in patients with cystic fibrosis. Pediatrics 1996;97:103-11.
53. Bonfield T, Panuska J, Konstan N, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med. 1995;152: 2111-6.
54. Seeman E. The effects of tobacco and alcohol use on bone. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. 1st edition. San Diego: Academic Press, 1996:577-94.
55. Cauley J, Gutai J, Kuller L, et al. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;124:752-61.
56. Hoppe J, Seeman E. Bone density in twins discordant for tobacco use. N Engl J Med 1994; 330:387-92.
57. Jensen LB, Quaade F, Sorensen OH. Bone loss accompanying voluntary weight loss in obese humans. J Bone Miner Res 1994;9:459-63.
58. Teramoto S, Matsuse T, Ouchi Y. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1997;103: 334-5.
59. Peters SG, McDougall JC, Scott JP, et al. Lung transplantation: selection of patients and analysis of outcome. Mayo Clin Proc 1997;72: 85-8.
60. Schâfers HJ, Wagner TO, Demertzis S, et al. Preoperative corticosteroids. A contraindication to lung transplantation? Chest 1992;102: 1522-5.
61. Ferrari S, Rizzoli R, Nicod L. Osteoporosis in patients undergoing lung transplantation. Chest 1997;111:257-8.
62. Aris R. Osteoporosis in patients undergoing lung transplantation. Chest 1997;111:257-8.
63. de Boer WJ, Mannes GPM, van der Bij W. Preoperative corticosteroids. A contraindication to lung transplantation? [letter]. Chest 1994;105:1908.
64. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. J Heart Lung Transplant 1998;17:703-9.
65. Lynch JP, Trulock EP. Recipient selection. Semin Repir Crit Care Med 1996;17:109-17.
66. Eastell R. Treatment of osteoporosis. N Engl J Med 1998;338:736-46.
67. Foresta C, Ruzza G, Mioni R, et al. Testosterone and bone loss in Klinefelter syndrome. Horm Metab Res 1983;15:56-7.
68. Biggar DG, Malen JF, Trulock EP, Cooper JD. Pulmonary rehabilitation before and after lung transplantation. In: Casaburi R, Petty TL, editors. Principles and practice of pulmonary rehabilitation. 1st edition. Philadelphia: WB Saunders, 1996:459-67.
69. Luckert B, Johnson B, Robinson R. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 1992;7:1063-9.
70. Adami S, Fossaluzza V, Rossini M, et al. The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate. Bone Miner 1991;15:72-81.
71. Reid IR, King AR, Alexander CJ, Ibbertson HK. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet 1988;1:143-6.
72. Adachi JD, Bensen WG, Brown J, Hanley D, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997;337:382-7.
73. Saag KG, Emkey R, Schnitzer TJ, Brown JP, et al. Alendronate for the prevention and treatment glucocorticoid-induced osteoporosis. N Engl J Med 1998;339:292-9.
74. Shane E, Bodino M, Thys-Jacobs S, Addeso V, et al. Comparison of two antiresorptive regimens on rates of bone loss after cardiac transplantation [abstract]. J Bone Miner Res 1997; 12(1 Suppl):S181.
75. Shane E, Rodino M, Thys Jackobs S, Adesso V, et al. A subset of patients lose bone after cardiac transplantation despite antiresorptive therapy [abstract]. J Bone Miner Res 1997;12(1 Suppl):S400.
76. Montemurro L, Schiraldi G, Fraioli P, Tosi G, Roboldi A, Rizzato G. Prevention of the corticoid induced-osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 1991;41:71-6.
77. Sambrook K, Birmingham J, Kelly P, Einsman J. Prevention of corticoid osteoporosis. A comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993;328:1747-52.
78. Rizzoli R, Chevalley T, Slosman D, Bonjour J. Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticoid induced osteoporosis. Osteoporos Int 1995;5:39-46.
79. Braith RW, Mills RM, Welsch MA, Keller JW, Pollock ML. Resistance exercise training restores bone mineral density in heart transplant recipients. J Am Coll Cardiol 1996;28:1471-7.
80. Sambrook P, Marshall G, Henderson K, Koegh A, et al. Effect of calcitriol in the prevention of bone loss after cardiac and lung transplantation [abstract]. J Bone Miner Res 1997;12(1 Suppl):S400.
81. Henderson N, Marshall G, Sambrook P, Keogh A, et al. Prevention of bone loss after heart or lung transplantation [abstract]. J Bone Miner Res 1997;12(1 Suppl):S400.
82. Rodino M, Shane E. Osteoporosis after organ transplantation. Review. Am J Med 1998;104: 459-69.